Literature DB >> 22553330

Activation of cap-dependent translation by mucosal human papillomavirus E6 proteins is dependent on the integrity of the LXXLL binding motif.

Jennifer M Spangle1, Nayana Ghosh-Choudhury, Karl Munger.   

Abstract

The human papillomavirus (HPV) type 16 (HPV16) E6 protein can stimulate mechanistic target of rapamycin complex 1 (mTORC1) signaling and cap-dependent translation through activation of the PDK1 and mTORC2 kinases. Here we report that HPV18 E6 also enhances cap-dependent translation. The integrity of LXXLL and PDZ protein binding domains is important for activation of cap-dependent translation by high-risk mucosal HPV E6 proteins. Consistent with this model, low-risk mucosal HPV6b and HPV11 E6 proteins, which do not contain a PDZ protein binding motif, also activate cap-dependent translation and mTORC1, albeit at a lower efficiency than high-risk HPV E6 proteins. In contrast, cutaneous HPV5 and HPV8 E6 proteins, which lack LXXLL and PDZ motif protein binding, do not enhance cap-dependent translation. Mutagenic analyses of low-risk HPV E6 proteins revealed that association with the LXXLL motif containing ubiquitin ligase E6AP (UBE3A) correlates with activation of cap-dependent translation. Hence, activation of mTORC1 and cap-dependent translation may be important for the viral life cycle in specific epithelial tissue types and contribute to cellular transformation in cooperation with other biological activities of high-risk HPV E6-containing proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22553330      PMCID: PMC3416298          DOI: 10.1128/JVI.00487-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

3.  Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells.

Authors:  Y Liu; J J Chen; Q Gao; S Dalal; Y Hong; C P Mansur; V Band; E J Androphy
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Gps2, a protein partner for human papillomavirus E6 proteins.

Authors:  Y Y Degenhardt; S J Silverstein
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types.

Authors:  M Thomas; L Banks
Journal:  J Gen Virol       Date:  1999-06       Impact factor: 3.891

6.  Morphoproteomic evidence of constitutively activated and overexpressed mTOR pathway in cervical squamous carcinoma and high grade squamous intraepithelial lesions.

Authors:  Wei Feng; Xiuzhen Duan; Jinsong Liu; Jianguo Xiao; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

7.  Human papillomavirus type 16 E7 oncoprotein associates with E2F6.

Authors:  Margaret E McLaughlin-Drubin; Kyung-Won Huh; Karl Münger
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

8.  Short RNAs repress translation after initiation in mammalian cells.

Authors:  Christian P Petersen; Marie-Eve Bordeleau; Jerry Pelletier; Phillip A Sharp
Journal:  Mol Cell       Date:  2006-02-17       Impact factor: 17.970

9.  E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation.

Authors:  Michael P Underbrink; Heather L Howie; Kristin M Bedard; Jennifer I Koop; Denise A Galloway
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

10.  Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.

Authors:  J J Chen; C E Reid; V Band; E J Androphy
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

View more
  23 in total

Review 1.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

2.  Network Analysis of UBE3A/E6AP-Associated Proteins Provides Connections to Several Distinct Cellular Processes.

Authors:  Gustavo Martínez-Noël; Katja Luck; Simone Kühnle; Alice Desbuleux; Patricia Szajner; Jeffrey T Galligan; Diana Rodriguez; Leon Zheng; Kathleen Boyland; Flavian Leclere; Quan Zhong; David E Hill; Marc Vidal; Peter M Howley
Journal:  J Mol Biol       Date:  2018-02-06       Impact factor: 5.469

3.  Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins.

Authors:  Miranda Grace; Karl Munger
Journal:  Virology       Date:  2016-10-20       Impact factor: 3.616

4.  High-risk human papillomavirus-18 uses an mRNA sequence to synthesize oncoprotein E6 in tumors.

Authors:  Alejandra García; Giovanna Maldonado; José L González; Yuri Svitkin; David Cantú; Alejandro García-Carrancá; Nahum Sonenberg; Greco Hernández
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-12       Impact factor: 11.205

5.  A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.

Authors:  Matthew G Fury; Eric Sherman; Alan L Ho; Han Xiao; Frank Tsai; Oby Nwankwo; Camelia Sima; Adrian Heguy; Nora Katabi; Sofia Haque; David G Pfister
Journal:  Cancer       Date:  2013-02-13       Impact factor: 6.860

6.  The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.

Authors:  Sydney Webb Strickland; Scott Vande Pol
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

7.  The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.

Authors:  Cindy Chiang; Eva-Katharina Pauli; Jennifer Biryukov; Katharina F Feister; Melissa Meng; Elizabeth A White; Karl Münger; Peter M Howley; Craig Meyers; Michaela U Gack
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

8.  Human papillomavirus in anal squamous cell carcinoma: an angel rather than a devil?

Authors:  Paola Simona Ravenda; Maria Giulia Zampino; Nicola Fazio; Massimo Barberis; Luca Bottiglieri; Susanna Chiocca
Journal:  Ecancermedicalscience       Date:  2015-04-29

Review 9.  The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.

Authors:  Lifang Zhang; Jianhong Wu; Ming Tat Ling; Liang Zhao; Kong-Nan Zhao
Journal:  Mol Cancer       Date:  2015-04-17       Impact factor: 27.401

10.  The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species.

Authors:  Jennifer M Spangle; Karl Munger
Journal:  PLoS Pathog       Date:  2013-03-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.